Elevated fibroblast growth factor 21 (FGF21) levels in obese, insulin resistant states are normalised by fenretinide treatment via retinoic acid signalling

N. Mody, Nicola Morrice, G. D. McIlroy, K. D. Shearer, P. J. McCaffery, M. Delibegovic

Research output: Contribution to journalAbstract

Original languageEnglish
Pages (from-to)48
Number of pages1
JournalDiabetic Medicine
Volume33
DOIs
Publication statusPublished - Mar 2016

Cite this

@article{3430f051b1b44e1db86876cadf2de1d5,
title = "Elevated fibroblast growth factor 21 (FGF21) levels in obese, insulin resistant states are normalised by fenretinide treatment via retinoic acid signalling",
author = "N. Mody and Nicola Morrice and McIlroy, {G. D.} and Shearer, {K. D.} and McCaffery, {P. J.} and M. Delibegovic",
year = "2016",
month = "3",
doi = "10.1111/dme.5_13048",
language = "English",
volume = "33",
pages = "48",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley",

}

TY - JOUR

T1 - Elevated fibroblast growth factor 21 (FGF21) levels in obese, insulin resistant states are normalised by fenretinide treatment via retinoic acid signalling

AU - Mody, N.

AU - Morrice, Nicola

AU - McIlroy, G. D.

AU - Shearer, K. D.

AU - McCaffery, P. J.

AU - Delibegovic, M.

PY - 2016/3

Y1 - 2016/3

U2 - 10.1111/dme.5_13048

DO - 10.1111/dme.5_13048

M3 - Abstract

VL - 33

SP - 48

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

ER -